Organon & Co | Fremdkapital



Loan Capital Veränderung Datum
Adcock Ingram Holdings ZAR 238.08M 21.45M 2024-06
Bristol-Myers Squibb USD 47.6B 1.07B 2024-12
Celltrion KRW 79.58B 21.94B 2024-09
Cspc Pharmaceutical CNY 66.32M 40.74M 2024-06
Dianthus Therapeutics USD 0 0 2024-09
Ecofibre AUD 9.5M 0 2024-06
Gilead Sciences USD 24.9B 3.46B 2024-12
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Kangmei Pharma CNY 169.19M 7.26M 2024-09
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 98.14M 45.9M 2024-06
Malin Corporation EUR 0 0 2024-06
Medical Developments International AUD 1.91M 146K 2024-06
Merck USD 34.46B 520M 2024-12
Neuren Pharmaceuticals AUD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Organigram Holdings CAD 43.29M 12.19M 2024-12
Organon & Co USD 8.74B 92M 2024-09
Pharma Mar EUR 41.23M 999K 2024-12
Qiagen NV USD 1.34B 26.51M 2024-12
Sartorius EUR 4.43B 106.8M 2024-09
Sino Biopharmaceutical CNY 1.16B 90.25M 2024-06
Tilray USD 316.63M 15.02M 2024-11



Organon & Co Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.